For example, KDM5A histone lysine demethylase inhibitor CPI-455 was reported to induce apoptosis and inhibit the proliferation of many tumor cells, such as cervical [62] and prostate cancer [63]. This evidence concerns the gene KDM5A and prostate carcinoma.